ArticleCancer immunology, immunotherapy : CII2021

Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study.

H M Stege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.